The world's first soluble insulin in China

On December 7, 2019, Novo Nordisk announced in Shanghai that the world's first soluble double insulin digumendon double insulin injection (novojia ®) was officially launched in China for the treatment of adult type 2 diabetes The launch of novojia ® in China has brought a new individualized solution for Chinese diabetes patients to achieve comprehensive blood glucose control As the first soluble double insulin preparation, novojia (digumendon double insulin injection) is a soluble preparation composed of 70% digumendon insulin and 30% aspart insulin It can effectively control fasting blood glucose and postprandial blood glucose, and the incidence of confirmatory hypoglycemia and night confirmatory hypoglycemia is low Before use, it does not need to be mixed evenly The way of administration is convenient, and it can effectively improve the compliance of patients 。 Novojia was approved for the first time in the world in December 2012 and has been listed in 26 countries and regions As it has obvious treatment advantages over the existing treatment methods, it was included in the national priority review and approval catalogue in September 2018, on May 24, 2019, The National Drug Administration (nmpa) approved the listing application of Novo Nordisk R & D and production of Novo Nordisk's Novo Nordisk ® (digumendonidine injection) in China for the treatment of adult type 2 diabetes, and officially approved the listing in China on December 7, 2019 The approval and marketing of novojia (digumendong double insulin injection) has brought a new solution for Chinese diabetes patients to achieve long-term comprehensive blood glucose control Mengmeng's article is the integrated content of yaozhi.com, and the copyright belongs to the original author The purpose of reprint is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.